Related Experiment Video
Updated: Aug 14, 2026

08:12
Calculating Heart Rate Variability from ECG Data from Youth with Cerebral Palsy During Active Video Game Sessions
Published on: June 5, 2019
Heart rate variability and Parkinson's disease severity
D Devos1, M Kroumova, R Bordet
1Department of Neurology, EA 2683, CHU Lille, France. d-devos@chru-lille.fr
Journal of Neural Transmission (Vienna, Austria : 1996)
|August 21, 2003
Summary
Heart rate variability (HRV) decreases with Parkinson's disease (PD) progression, independent of motor activity. This autonomic dysfunction worsens as PD advances, impacting cardiovascular regulation.
Area of Science:
- Neurology
- Cardiology
- Autonomic Nervous System Research
Background:
- Heart rate variability (HRV) reduction is observed in Parkinson's disease (PD), but its cause—whether motor activity or autonomic dysfunction—remains debated.
- Understanding HRV changes in PD is crucial for assessing disease severity and potential cardiovascular complications.
Purpose of the Study:
- To investigate the relationship between disease progression, motor activity, and HRV in Parkinson's disease patients.
- To differentiate the impact of motor impairment versus autonomic dysfunction on HRV.
Main Methods:
- Continuous HRV monitoring was performed on 30 PD patients across three disease stages and compared to controls under standardized motor activity.
- Analysis included diurnal and nocturnal HRV parameters, specifically low frequency (LF) power, high frequency (HF) power, and the LF/HF ratio.
Main Results:
- No significant HRV differences were found in early-stage PD (Group I) compared to controls.
- Diurnal LF power and LF/HF ratio decreased in moderate (Group II) and advanced (Group III) PD.
- Nocturnal vagal indicators (HF power, pNN50) were reduced in advanced PD (Group III) and correlated with motor handicap during 'off' medication periods.
Conclusions:
- HRV decrease in Parkinson's disease is linked to disease severity and autonomic dysfunction, not solely motor activity.
- Cardiovascular dysautonomia progresses with PD, indicated by reduced HRV, particularly during 'off' drug states.
- Advanced PD may exhibit impaired cardiovascular up-regulation, even with increased motor activity like dyskinesias.
Related Concept Videos
Factors Influencing Heart Rate
The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

